8-K: VERSES AI Inc. Prices $7 Million Public Offering to Fuel AI Development and Operations

VERSES AI Inc. has priced a public offering of 1,007,764 units at $6.946 per unit, aiming to raise approximately $7 million in gross proceeds to bolster its financial position and advance research and development.

Summary

• VERSES AI Inc. announced the pricing of a public offering of 1,007,764 units at US$6.946 (CDN$9.50) per unit, expecting to generate gross proceeds of US$7,000,331 (CDN$9,573,758).
• Each unit consists of one Class A subordinate voting share and one-half of one transferable Class A subordinate voting share purchase warrant.
• Each whole warrant entitles the holder to acquire one Class A subordinate voting share at an exercise price of US$8.409 (CDN$11.50) per share for a period of three years following the closing of the offering.
• A.G.P. Canada Investments ULC is acting as lead agent, and A.G.P./Alliance Global Partners is acting as U.S. agent for the offering.
• The Company will pay the agents a cash fee of 7% of the aggregate gross proceeds, reduced to 2% for purchasers identified by the Company (Presidents List), subject to a minimum fee of CDN$400,000.
• VERSES AI Inc. will also issue compensation warrants to the agents equal to 3.5% of the aggregate number of units sold, reduced to 2% for Presidents List purchasers, exercisable at US$8.409 (CDN$11.50) for three years.
• The Company has agreed to reimburse agents for certain expenses and legal fees up to US$100,000 for the offering and up to US$300,000 for legal fees from previous transactions, plus non-accountable expenses up to CAD$25,000.
• The offering is expected to close on July 11, 2025, subject to customary closing conditions and Cboe Canada Inc. approval.
• The net proceeds are intended to strengthen the Company's financial position, provide liquidity, finance ongoing operations (particularly research and development), and for working capital and general corporate purposes.

Sentiment

Score: 6

Explanation: The capital raise provides essential funding for VERSES AI Inc.'s operations and R&D, which is positive for its long-term strategic goals. However, the offering involves significant dilution for existing shareholders and substantial fees, which temper the overall positive sentiment.

Positives

• The offering is expected to raise significant gross proceeds of US$7,000,331 (CDN$9,573,758), strengthening the Company's financial position and providing liquidity.
• Proceeds will be used to finance ongoing operations, including critical research and development objectives, which are essential for an AI company's growth.
• The offering provides working capital and funds for general corporate purposes, supporting overall business continuity and expansion.
• The Company's Subordinate Voting Shares are listed on Cboe, and the Unit Shares, Warrant Shares, and Compensation Warrant Shares have been approved for listing, subject to customary conditions, indicating continued market access.

Negatives

• The offering involves the issuance of new shares and warrants, which will result in dilution for existing shareholders.
• Significant fees and expenses are associated with the offering, including a 7% cash fee to agents (minimum CDN$400,000), compensation warrants (3.5% of units sold), and up to US$400,000 in legal and other expenses.
• The 'reasonable best efforts' basis for the offering means there is no guarantee that all units will be sold or that the full target proceeds will be raised.
• The Company has granted A.G.P. Canada an irrevocable right of first refusal for 12 months on future equity or debt offerings, potentially limiting future financing options or increasing costs.

Risks

• The offering may not be completed on the anticipated timetable or at all.
• The Company may not be able to price the offering as announced.
• Failure to obtain all necessary approvals, including from Cboe Canada Inc. and applicable securities regulatory authorities, could prevent the offering's completion.
• Volatility in global capital markets could negatively impact the offering and the development of the Company's business.
• The actual use of proceeds from the offering may differ from management's current expectations.
• The Company's ability to enforce agreements may be limited by bankruptcy, insolvency, reorganization, moratorium laws, and equitable principles.
• There is no guarantee of continued compliance with Canadian Securities Laws or U.S. Securities Laws, subject to directors' fiduciary duties.
• Maintaining the listing of Subordinate Voting Shares on Cboe is subject to directors' fiduciary duties and potential take-over bids.
• The Company's compliance with the European Union Artificial Intelligence Act and other applicable AI laws and regulations is an ongoing effort, with potential for material liability if non-compliance occurs.
• Security breaches or compromises of the Company's IT Systems and Data, including customer, employee, and third-party data, pose a risk.
• Failure to protect personal information against illegal or unauthorized access or use could lead to violations of privacy laws.
• Non-compliance with anti-corruption, money laundering, or sanctions laws could result in legal and financial penalties.
• The Company could become a 'covered foreign person' or engage in 'covered activity' under U.S. Department of Treasury regulations, potentially leading to restrictions.

Future Outlook

The Company expects to close the sale of the units on July 11, 2025, subject to customary closing conditions and necessary approvals. The net proceeds from the offering are intended to strengthen the Company's financial position, provide liquidity, and finance ongoing operations, particularly research and development objectives, as well as for working capital and general corporate purposes. The Company will also maintain its status as a reporting issuer and seek to maintain the listing of its Subordinate Voting Shares on Cboe until the expiry date of the warrants.

Management Comments

• Gabriel Ren, Co-Founder & CEO, is listed as a contact for media and investor relations inquiries.
• James Christodoulou, Chief Financial Officer, is listed as a contact for media and investor relations inquiries and signed the Form 8-K.

Industry Context

This public offering by VERSES AI Inc., a cognitive computing company, reflects a common strategy for technology firms, especially in the AI sector, to raise capital for ongoing research and development, and to scale operations. The significant investment in R&D aligns with the rapid innovation cycles and competitive landscape within the artificial intelligence industry, where continuous technological advancement is crucial for market positioning and growth. The capital raise also indicates a need for liquidity to support operational expansion in a high-growth, capital-intensive sector.

Comparison to Industry Standards

• NA The document does not provide specific comparable companies, projects, or results to assess the offering terms against global benchmarks. The offering terms (unit price, warrant exercise price, agent fees) are specific to VERSES AI Inc. and would require external market data for a meaningful comparison to industry standards for similar-stage AI companies or public offerings.

Corporate Governance

Related Party Transactions

• The document states that there are no business relationships or related-party transactions involving the Company, or any other person required by applicable Securities Laws to be described in the Registration Statement, the Preliminary Prospectuses, the General Disclosure Package and the Final Prospectuses that have not been described as required.
• Except for wages, salaries and other compensation-related payments in the ordinary course, and other than as disclosed in the Registration Statement, the Preliminary Prospectuses, the General Disclosure Package or the Final Prospectuses, the Company is not indebted to any director, officer or shareholder of the Company, any individual related to any of the foregoing by blood, marriage or adoption, or any corporation controlled, directly or indirectly, by any one or more of those persons.

Stakeholder Impact

• **Shareholders**: Will experience dilution due to the issuance of new Class A subordinate voting shares and warrants. However, the capital raise strengthens the Company's financial position, potentially supporting future growth and value creation.
• **Investment Professionals/Agents (A.G.P. Canada, A.G.P. U.S.)**: Will receive significant cash fees (7% of gross proceeds, minimum CDN$400,000) and compensation warrants (3.5% of units sold), along with expense reimbursements, providing substantial compensation for their services.
• **Employees**: The capital raise provides funding for ongoing operations, including research and development, which could support job security and future growth opportunities within the Company.
• **Creditors**: The strengthening of the Company's financial position and increased liquidity could improve its ability to meet existing and future financial obligations.
• **Customers/Suppliers**: Enhanced financial stability and continued investment in R&D could lead to improved products/services and more stable business relationships.

Next Steps

• File the Final Prospectus Supplement with the SEC and Canadian Qualifying Authorities.
• Close the sale of the Units on July 11, 2025, subject to customary closing conditions.
• Enter into a warrant indenture with Endeavor Trust Corporation relating to the Warrants.
• Maintain status as a reporting issuer under Canadian and U.S. securities laws.
• Maintain listing of Subordinate Voting Shares (including new shares) on Cboe.
• Directors and senior officers to enter into 30-day lock-up undertakings.
• A.G.P. Canada to have a 12-month right of first refusal for future equity or debt offerings.
• Company to continue efforts to comply with the European Union Artificial Intelligence Act and other applicable AI laws.

Key Dates

Recommendation

Keywords

VERSES AI Inc., Public Offering, Units, Subordinate Voting Shares, Warrants, Capital Raise, SEC Filing, 8-K, AI, Cognitive Computing, Financial Reporting, Equity Financing, Cboe, SEDAR+, EDGAR, Dilution, Research and Development, Working Capital